Concord Wealth Partners Evoke Pharma Inc Transaction History

Concord Wealth Partners

  • $591 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Apr 30, 2024
BUY
$0.96 - $1.73 $29 - $53
31 New
31 $0
Q2 2023

Aug 07, 2023
SELL
$1.39 - $2.25 $115 - $186
-83 Reduced 72.81%
31 $0
Q1 2023

Apr 26, 2023
BUY
$1.89 - $5.75 $215 - $655
114 New
114 $0

Others Institutions Holding EVOK

# of Institutions
1
Shares Held
1.46K
Call Options Held
0
Put Options Held
0
View Full List

About Evoke Pharma Inc

EVOK Quotes by TradingView
  • Ticker EVOK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,343,070
  • Market Cap $1.57M
  • Description
  • Evoke Pharma, Inc., a specialty pharmaceutical company, primarily focuses on the development and commercialization of drugs for the treatment of gastroenterological disorders and diseases. It is developing Gimoti, a metoclopramide nasal spray that has completed Phase 3 clinical trials to treat symptoms associated with acute and recurrent diabeti...
More about EVOK
Track This Portfolio

Track Concord Wealth Partners Portfolio

Follow Concord Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email